slides · global inventory
Traction
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 10,471
Current window 5,371-5,400
Pages 350
Rows per page 30
Slide type
5,371-5,400 of 10,471
13
The slide highlights financial stability and operational health metrics.Cyxtera | Investor Presentation Deck | 28 slides · Cyxtera
Pitch deck Investor relations 1 hit
14
The slide uses a stacked bar chart to show revenue composition and a pie chart to show contract duration distribution.Cyxtera | Investor Presentation Deck | 28 slides · Cyxtera
Pitch deck Investor relations 1 hit
20
Includes revenue breakdown by segment (Lumen/Core), churn rates, and EBITDA growth projections through 2027E.Cyxtera | Investor Presentation Deck | 28 slides · Cyxtera
Pitch deck Investor relations 1 hit
24
The slide highlights underperformance relative to budget in both bookings and churn.Cyxtera | Investor Presentation Deck | 28 slides · Cyxtera
Pitch deck Investor relations 1 hit
03
The slide uses a 3x2 grid of metrics to demonstrate market dominance and financial health.Doximity | Investor Presentation Deck | 18 slides · Doximity
Pitch deck Investor relations 1 hit
12
The slide uses a waffle chart (grid of boxes) to represent market penetration segments and a pie chart to summarize total budget share.Doximity | Investor Presentation Deck | 18 slides · Doximity
Pitch deck Investor relations 1 hit
13
The slide uses a dual-chart layout to contrast customer acquisition growth with retention and revenue growth metrics.Doximity | Investor Presentation Deck | 18 slides · Doximity
Pitch deck Investor relations 1 hit
14
Includes CAGR metrics for both revenue and EBITDA.Doximity | Investor Presentation Deck | 18 slides · Doximity
Pitch deck Investor relations 1 hit
06
Includes company origin, location, and a series of high-level KPIs.Dragonfly Energy | Investor Presentation Deck | 25 slides · Dragonfly Energy
Pitch deck Investor relations 1 hit
23
Dragonfly Energy | Investor Presentation Deck | 25 slidesDragonfly Energy | Investor Presentation Deck | 25 slides · Dragonfly Energy
Pitch deck Investor relations 1 hit
24
Includes annotations for 'DFLI goes public' on the EBITDA charts.Dragonfly Energy | Investor Presentation Deck | 25 slides · Dragonfly Energy
Pitch deck Investor relations 1 hit
05
The slide uses a large background photo of a solar farm to provide context for the metrics.Eos Energy | Investor Presentation Deck | 16 slides · Eos Energy Enterprises, Inc.
Pitch deck Investor relations 1 hit
11
The slide uses a timeline framework to visualize the transition from facility construction to full production and subsequent transition to a new product generation.Eos Energy | Investor Presentation Deck | 16 slides · Eos Energy Enterprises, Inc.
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
15
Includes a detailed funding table and three key performance charts.Eos Energy | Investor Presentation Deck | 16 slides · Eos Energy Enterprises, Inc.
Pitch deck Investor relations Beat · Financials1 hit
16
The slide uses a structured list format to present three core pillars of progress.Eos Energy | Investor Presentation Deck | 16 slides · Eos Energy Enterprises, Inc.
Pitch deck Investor relations Beat · Financials1 hit
10
The chart demonstrates a V-shaped recovery post-Q2 2020 and sustained growth above 2019 levels.European Wax Center | Investor Presentation Deck | 25 slides · European Wax Center
Pitch deck Investor relations Beat · Traction1 hit
11
Uses a causal chain/equation-like visual structure (A + B = C) to explain performance.European Wax Center | Investor Presentation Deck | 25 slides · European Wax Center
Pitch deck Investor relations Beat · Traction1 hit
19
Includes a table at the bottom of the charts showing net new centers, % SSS, and % growth.European Wax Center | Investor Presentation Deck | 25 slides · European Wax Center
Pitch deck Investor relations Beat · Financial Performance1 hit
20
Includes SSS (Same-Store Sales) metrics and margin percentages.European Wax Center | Investor Presentation Deck | 25 slides · European Wax Center
Pitch deck Investor relations Beat · Financial Performance1 hit
05
TPD = Targeted Protein Degradation; PK = Pharmacokinetics; PD = Pharmacodynamics; HS = Hidradenitis Suppurativa; AD = Atopic Dermatitis.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
12
The slide uses a split-screen comparison between healthy volunteer data and patient data.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
13
The slide uses a bulleted list structure to categorize findings between healthy volunteers and patients, concluding with a strategic partnership milestone.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
16
HS = Hidradenitis Suppurativa; AD = Atopic Dermatitis; HV = Healthy Volunteers; MAD = Multiple Ascending Dose; LLOQ = Lower Limit of Quantitation.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
17
The chart shows a clear reduction in IRAK4 protein levels in both AD and HS patient groups after 28 days of treatment, bringing them down to or below the baseline levels of healthy subjects.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
18
The slide compares cytokine inhibition efficacy in Healthy Subjects (MAD3), AD patients, and HS patients using two different stimulation methods (LPS and R848).Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
19
The chart specifically visualizes IL-6 reduction over time, while the table summarizes max reduction across four markers.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
21
Data presented as mean percentage change with standard error bars; N=7.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
22
The chart tracks patient outcomes over time, showing a shift from severe/moderate to mild categories.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
24
The slide uses a comparison table to highlight efficacy metrics (EASI, Pruritus NRS) across different time points and benchmarks.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
25
Data compares 'All HS Patients' vs 'Moderate to Severe' subgroups. Includes error bars representing standard error of the mean or 80% confidence intervals.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit